Comparative Pharmacology
Head-to-head clinical analysis: INDAPAMIDE versus MYKROX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: INDAPAMIDE versus MYKROX.
INDAPAMIDE vs MYKROX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Indapamide is a thiazide-like diuretic that inhibits sodium reabsorption in the distal convoluted tubule by blocking the Na-Cl cotransporter, leading to increased excretion of sodium, chloride, and water. It also reduces peripheral vascular resistance through direct vasodilatory effects.
MYKROX (metolazone) is a thiazide-like diuretic that inhibits sodium reabsorption in the distal convoluted tubule by blocking the Na+-Cl- cotransporter, leading to increased excretion of sodium, chloride, and water.
1.25-2.5 mg orally once daily; 2.5 mg is usual maintenance dose; maximum 5 mg/day.
Adults: 1 mg orally once daily, preferably in the morning.
None Documented
None Documented
Clinical Note
moderateIndapamide + Digoxin
"The risk or severity of adverse effects can be increased when Indapamide is combined with Digoxin."
Clinical Note
moderateIndapamide + Digitoxin
"The risk or severity of adverse effects can be increased when Indapamide is combined with Digitoxin."
Clinical Note
moderateIndapamide + Deslanoside
"The risk or severity of adverse effects can be increased when Indapamide is combined with Deslanoside."
Clinical Note
moderateIndapamide + Acetyldigitoxin
14–18 hours (terminal elimination half-life); prolonged in renal impairment, supporting once-daily dosing.
Terminal elimination half-life: 50–70 hours; achieves steady-state after ~2 weeks of once-daily dosing; prolonged in hepatic impairment but not significantly altered in renal impairment.
Renal excretion (70% unchanged, 23% as glucuronide conjugate); biliary/fecal elimination accounts for <5%.
Primarily hepatic metabolism (CYP3A4) to inactive metabolites; renal excretion accounts for <10% as unchanged drug; biliary/fecal excretion of metabolites ~75%.
Category A/B
Category C
Thiazide-like Diuretic
Thiazide-like Diuretic
"The risk or severity of adverse effects can be increased when Indapamide is combined with Acetyldigitoxin."